Drugs and Devices

FDA to strengthen review of AEDs

On January 28, the U.S. Food and Drug Administration (FDA) announced that it will strengthen its review of automated external defibrillators (AEDs) to help improve the quality and reliability of these devices. Read more.


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares